Joel R. Gever

1.9k total citations
33 papers, 1.6k citations indexed

About

Joel R. Gever is a scholar working on Molecular Biology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Joel R. Gever has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Physiology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Joel R. Gever's work include Adenosine and Purinergic Signaling (13 papers), Prion Diseases and Protein Misfolding (9 papers) and Neuroscience of respiration and sleep (6 papers). Joel R. Gever is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Prion Diseases and Protein Misfolding (9 papers) and Neuroscience of respiration and sleep (6 papers). Joel R. Gever collaborates with scholars based in United States, United Kingdom and Switzerland. Joel R. Gever's co-authors include Anthony Ford, Michael P. Dillon, Geoffrey Burnstock, Debra A. Cockayne, Donald V. Daniels, David E. Clarke, Stanley B. Prusiner, Jeffrey R. Jasper, B. Michael Silber and John Lesnick and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Joel R. Gever

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel R. Gever United States 20 684 573 313 302 282 33 1.6k
William A. Carroll United States 21 501 0.7× 588 1.0× 139 0.4× 251 0.8× 213 0.8× 44 1.5k
Susanna M.O. Hourani United Kingdom 26 678 1.0× 1.1k 1.9× 299 1.0× 483 1.6× 373 1.3× 56 2.0k
Timothy D. Westfall United Kingdom 20 348 0.5× 425 0.7× 232 0.7× 155 0.5× 141 0.5× 29 1.1k
Günter Lambrecht Germany 30 1.3k 1.9× 1.2k 2.1× 514 1.6× 707 2.3× 371 1.3× 84 2.7k
Anton D. Michel United Kingdom 28 1.3k 1.9× 863 1.5× 285 0.9× 917 3.0× 594 2.1× 55 2.6k
Edward Leung Italy 24 1.0k 1.5× 1.1k 2.0× 70 0.2× 379 1.3× 156 0.6× 52 2.2k
Bhalchandra V. Joshi United States 23 788 1.2× 1.1k 1.9× 106 0.3× 261 0.9× 189 0.7× 46 2.0k
Hermann Nawrath Germany 29 1.6k 2.4× 190 0.3× 56 0.2× 690 2.3× 466 1.7× 106 2.5k
N Ambache United Kingdom 20 635 0.9× 80 0.1× 134 0.4× 600 2.0× 442 1.6× 59 1.8k
Mark E. Olah United States 28 2.3k 3.4× 2.8k 4.8× 251 0.8× 1.1k 3.5× 302 1.1× 59 4.0k

Countries citing papers authored by Joel R. Gever

Since Specialization
Citations

This map shows the geographic impact of Joel R. Gever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel R. Gever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel R. Gever more than expected).

Fields of papers citing papers by Joel R. Gever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel R. Gever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel R. Gever. The network helps show where Joel R. Gever may publish in the future.

Co-authorship network of co-authors of Joel R. Gever

This figure shows the co-authorship network connecting the top 25 collaborators of Joel R. Gever. A scholar is included among the top collaborators of Joel R. Gever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel R. Gever. Joel R. Gever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matt, Rachel A., et al.. (2023). Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles. Frontiers in Molecular Biosciences. 10. 1214102–1214102. 2 indexed citations
2.
Matt, Rachel A., Renée S. Martin, Andrew K. Evans, et al.. (2023). Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease. Handbook of experimental pharmacology. 285. 555–616. 4 indexed citations
3.
Ford, Anthony, Michael P. Dillon, Michael M. Kitt, & Joel R. Gever. (2021). The discovery and development of gefapixant. Autonomic Neuroscience. 235. 102859–102859. 10 indexed citations
4.
Abdala, Ana P., Wioletta Pijacka, Hélio César Salgado, et al.. (2020). P2X3 receptor antagonism reduces the occurrence of apnoeas in newborn rats. Respiratory Physiology & Neurobiology. 277. 103438–103438. 7 indexed citations
5.
Silber, B. Michael, Joel R. Gever, Zhe Li, et al.. (2014). Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells. Bioorganic & Medicinal Chemistry. 22(6). 1960–1972. 19 indexed citations
6.
Lü, Duo, Kurt Giles, Zhe Li, et al.. (2013). Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice. Journal of Pharmacology and Experimental Therapeutics. 347(2). 325–338. 32 indexed citations
7.
Silber, B. Michael, Alejandra Gallardo‐Godoy, Adam R. Renslo, et al.. (2013). Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice. Pharmaceutical Research. 30(4). 932–950. 26 indexed citations
8.
Dehdashti, Seameen, Wei Zheng, Joel R. Gever, et al.. (2013). A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein. Current Alzheimer Research. 10(7). 679–687. 18 indexed citations
9.
Yip, Ping K., John Grist, Joel R. Gever, et al.. (2010). Selective blockade of spinal P2X3 and P2X2/3 receptors with a novel and selective antagonist, AF-742, reveals central endogenous purinergic regulation of bladder activity. 1 indexed citations
10.
Gever, Joel R., Robert Henningsen, Renée S. Martin, et al.. (2010). AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. British Journal of Pharmacology. 160(6). 1387–1398. 108 indexed citations
11.
Dillon, Michael P., Anthony Ford, Joel R. Gever, et al.. (2009). Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 20(3). 1031–1036. 36 indexed citations
12.
Carter, David S., Haiying Cai, Michael P. Dillon, et al.. (2009). Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 19(6). 1628–1631. 54 indexed citations
13.
Gever, Joel R., Debra A. Cockayne, Michael P. Dillon, Geoffrey Burnstock, & Anthony Ford. (2006). Pharmacology of P2X channels. Pflügers Archiv - European Journal of Physiology. 452(5). 513–537. 253 indexed citations
14.
Ford, Anthony, Joel R. Gever, Philip A. Nunn, et al.. (2006). Purinoceptors as therapeutic targets for lower urinary tract dysfunction. British Journal of Pharmacology. 147(S2). S132–43. 103 indexed citations
15.
Bley, Keith, Anindya Bhattacharya, Joel R. Gever, et al.. (2005). RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. British Journal of Pharmacology. 147(3). 335–345. 89 indexed citations
16.
Jaime‐Figueroa, Saul, et al.. (2005). Discovery and synthesis of a novel and selective drug-like P2X1 antagonist. Bioorganic & Medicinal Chemistry Letters. 15(13). 3292–3295. 21 indexed citations
17.
Hu, Dong‐Qing, et al.. (2004). 1745: Cystometric Studies with ATP, PPADS and TNP-ATP in Conscious and Anesthetized C57BL/6 Mice. The Journal of Urology. 171(4S). 461–462. 7 indexed citations
18.
Blue, David R., Donald V. Daniels, Joel R. Gever, et al.. (2003). Pharmacological characteristics of Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence. British Journal of Urology. 93(1). 162–170. 33 indexed citations
19.
Lachnit, Wilhelm, Ian B. Oglesby, Joel R. Gever, et al.. (2000). Regulated expression of the rat recombinant P2X3 receptor in stably transfected CHO-K1 tTA cells. Journal of the Autonomic Nervous System. 81(1-3). 75–81. 9 indexed citations
20.
Daniels, Donald V., Joel R. Gever, Jeffrey R. Jasper, et al.. (1999). Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies. European Journal of Pharmacology. 370(3). 337–343. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William A. Carroll Breakdown of academic impact, for papers by Susanna M.O. Hourani Breakdown of academic impact, for papers by Timothy D. Westfall Breakdown of academic impact, for papers by Günter Lambrecht Breakdown of academic impact, for papers by Anton D. Michel Breakdown of academic impact, for papers by Edward Leung Breakdown of academic impact, for papers by Bhalchandra V. Joshi Breakdown of academic impact, for papers by Hermann Nawrath Breakdown of academic impact, for papers by N Ambache Breakdown of academic impact, for papers by Mark E. Olah
Rankless by CCL
2026